資產檔案
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the tre…
最新在前。
同一家公司在本板塊內追蹤的其他藥物和在研候選。